Makena Active Ingredient Compounding Ban Would Be Limited To Preterm Birth Prevention

 
• By Sue Sutter
  
Mortar and pestle
The FDA is proposing to prohibit compounding of Makena's active ingredient for preventing preterm birth. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US Advisory Committees

More from Geography